Akari Therapeutics PLC (AKTX)

2.40 -0.03 (-1.21%) USD  |  NASDAQ  |  Nov 05, 11:21
More

Akari Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
December 05, 2022 --
Date Value
April 23, 2021 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

--
Minimum
Apr 23 2021
--
Maximum
Apr 23 2021
--
Average
--
Median
Apr 23 2021

Revenue Estimates for Current Fiscal Year Benchmarks

DBV Technologies SA Upgrade
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC Upgrade
NuCana PLC Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade